ACHC

Acadia Healthcare Company, Inc. Common Stock

ACHC
Closed
$30.97
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The company is headquartered in Franklin, Tennessee and currently employs 19,000 full-time employees. The company went IPO on 2011-11-01. The firm owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. The company provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting.
Country

US

CEO

Ms. Debra Osteen

IPO date

2011

Employees

19,000

ISIN

US00404A1097

Key stats

Open

$31.20

Volume

3.00M

Market cap

$2.83B

Prev. close

$31.40

Impl / hst vl

-

Open interest

$0.00

$30.97

Day’s Range

$32.56

$11.56

52W Range

$32.82

Valuation

33
Valuation score
Overvalued
P/E
-
P/S
0.84
P/B
1.44
Current ratio
1.71
Debt / Equity
1.21
ROE
-43.82%
Gross margin
-
Income growth
-100.35%
FCF growth
-91.62

Analysts estimates

Consensus rating
Buy

The average rating from top 8 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$29.43
The top 16 analysts forecasts that 12-month price may decrease by 4.96%, with a low of $13.13 and a high of $40.95
$13.13
Low
$29.43
Avg
$40.95
High
Current price

Earnings

Q1 ‘26 revenue
$828.80M
Q1 ‘26 net income
$4.11M
Revenue
Net income
Previous EPS
$0.37
Estimate EPS
$0.37
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply